167 related articles for article (PubMed ID: 15379550)
1. Fetal Alz-50 clone 1 interacts with the human orthologue of the Kelch-like Ech-associated protein.
Strachan GD; Morgan KL; Otis LL; Caltagarone J; Gittis A; Bowser R; Jordan-Sciutto KL
Biochemistry; 2004 Sep; 43(38):12113-22. PubMed ID: 15379550
[TBL] [Abstract][Full Text] [Related]
2. Expression of the fetal Alz-50 clone 1 protein induces apoptotic cell death.
Strachan GD; Ostrow LA; Jordan-Sciutto KL
Biochem Biophys Res Commun; 2005 Oct; 336(2):490-5. PubMed ID: 16137655
[TBL] [Abstract][Full Text] [Related]
3. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis.
Stępkowski TM; Kruszewski MK
Free Radic Biol Med; 2011 May; 50(9):1186-95. PubMed ID: 21295136
[TBL] [Abstract][Full Text] [Related]
4. Fetal Alz-50 clone 1 (FAC1) protein interacts with the Myc-associated zinc finger protein (ZF87/MAZ) and alters its transcriptional activity.
Jordan-Sciutto KL; Dragich JM; Caltagarone J; Hall DJ; Bowser R
Biochemistry; 2000 Mar; 39(12):3206-15. PubMed ID: 10727212
[TBL] [Abstract][Full Text] [Related]
5. DNA binding activity of the fetal Alz-50 clone 1 (FAC1) protein is enhanced by phosphorylation.
Jordan-Sciutto KL; Dragich JM; Bowser R
Biochem Biophys Res Commun; 1999 Jul; 260(3):785-9. PubMed ID: 10403843
[TBL] [Abstract][Full Text] [Related]
6. Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway.
Yu M; Li H; Liu Q; Liu F; Tang L; Li C; Yuan Y; Zhan Y; Xu W; Li W; Chen H; Ge C; Wang J; Yang X
Cell Signal; 2011 May; 23(5):883-92. PubMed ID: 21262351
[TBL] [Abstract][Full Text] [Related]
7. Fetal Alz-50 clone 1, a novel zinc finger protein, binds a specific DNA sequence and acts as a transcriptional regulator.
Jordan-Sciutto KL; Dragich JM; Rhodes JL; Bowser R
J Biol Chem; 1999 Dec; 274(49):35262-8. PubMed ID: 10575013
[TBL] [Abstract][Full Text] [Related]
8. Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2.
Eggler AL; Liu G; Pezzuto JM; van Breemen RB; Mesecar AD
Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10070-5. PubMed ID: 16006525
[TBL] [Abstract][Full Text] [Related]
9. Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome.
Katoh Y; Iida K; Kang MI; Kobayashi A; Mizukami M; Tong KI; McMahon M; Hayes JD; Itoh K; Yamamoto M
Arch Biochem Biophys; 2005 Jan; 433(2):342-50. PubMed ID: 15581590
[TBL] [Abstract][Full Text] [Related]
10. Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes.
Karapetian RN; Evstafieva AG; Abaeva IS; Chichkova NV; Filonov GS; Rubtsov YP; Sukhacheva EA; Melnikov SV; Schneider U; Wanker EE; Vartapetian AB
Mol Cell Biol; 2005 Feb; 25(3):1089-99. PubMed ID: 15657435
[TBL] [Abstract][Full Text] [Related]
11. Keap1 regulates the oxidation-sensitive shuttling of Nrf2 into and out of the nucleus via a Crm1-dependent nuclear export mechanism.
Velichkova M; Hasson T
Mol Cell Biol; 2005 Jun; 25(11):4501-13. PubMed ID: 15899855
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of the Nrf1 transcription factor by its N-terminal domain is independent of Keap1: Nrf1, but not Nrf2, is targeted to the endoplasmic reticulum.
Zhang Y; Crouch DH; Yamamoto M; Hayes JD
Biochem J; 2006 Nov; 399(3):373-85. PubMed ID: 16872277
[TBL] [Abstract][Full Text] [Related]
13. Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes.
Kang MI; Kobayashi A; Wakabayashi N; Kim SG; Yamamoto M
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2046-51. PubMed ID: 14764898
[TBL] [Abstract][Full Text] [Related]
14. Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1.
Nguyen T; Sherratt PJ; Nioi P; Yang CS; Pickett CB
J Biol Chem; 2005 Sep; 280(37):32485-92. PubMed ID: 16000310
[TBL] [Abstract][Full Text] [Related]
15. Fuzzy complex formation between the intrinsically disordered prothymosin α and the Kelch domain of Keap1 involved in the oxidative stress response.
Khan H; Cino EA; Brickenden A; Fan J; Yang D; Choy WY
J Mol Biol; 2013 Mar; 425(6):1011-27. PubMed ID: 23318954
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles.
Itoh K; Tong KI; Yamamoto M
Free Radic Biol Med; 2004 May; 36(10):1208-13. PubMed ID: 15110385
[TBL] [Abstract][Full Text] [Related]
17. FAC1, a novel gene identified with the monoclonal antibody Alz50, is developmentally regulated in human brain.
Bowser R; Giambrone A; Davies P
Dev Neurosci; 1995; 17(1):20-37. PubMed ID: 7621746
[TBL] [Abstract][Full Text] [Related]
18. The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm.
Zipper LM; Mulcahy RT
J Biol Chem; 2002 Sep; 277(39):36544-52. PubMed ID: 12145307
[TBL] [Abstract][Full Text] [Related]
19. Ultraviolet A irradiation induces NF-E2-related factor 2 activation in dermal fibroblasts: protective role in UVA-induced apoptosis.
Hirota A; Kawachi Y; Itoh K; Nakamura Y; Xu X; Banno T; Takahashi T; Yamamoto M; Otsuka F
J Invest Dermatol; 2005 Apr; 124(4):825-32. PubMed ID: 15816842
[TBL] [Abstract][Full Text] [Related]
20. Expression of fetal ALZ-50 reactive clone 1 (FAC1) in dentate gyrus following entorhinal cortex lesion.
Styren SD; Bowser R; Dekosky ST
J Comp Neurol; 1997 Oct; 386(4):555-61. PubMed ID: 9378851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
